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Background: While aggressive endoluminal therapy for superficial femoral artery (SFA) occlusive disease is commonplace,
the implications of runoff on long-term outcomes of these interventions in patients with rest pain and tissue loss is
unclear. Runoff is known to negatively effect graft patency. The aim of this study is to examine the impact of distal runoff
on long-term outcomes of SFA interventions for critical ischemia.
Methods: A prospective database of patients undergoing endovascular treatment of the SFA between 1986 and 2007 was
queried. Patients with Rutherford symptom classification 4, 5, and 6 were selected. Patients with concomitant tibial
interventions were excluded. Pre-operative angiograms were reviewed in all cases to assess distal popliteal and tibial
runoff and were scored according to modified Society of Vascular Surgery criteria for both vessels such that a higher score
implies worse runoff (minimum 1 and maximum 19). Three runoff score groups were identified: <5 (Good), 5-10
(Compromised), and >10 (Poor). Kaplan-Meier survival analyses were performed to assess time-dependent outcomes.
Multivariate and Factor analyses were performed.
Results: Three hundred six limbs in 241 patients (57% male, mean age 68 years) underwent endovascular treatment for
critical ischemia (44% rest pain and 56% tissue loss.) Technical success was 96% with 61% SFA undergoing angioplasty,
37% SFA primary stenting and 2% SFA an atherectomy. Overall mortality was 1% and overall morbidity was 16% at 90
days after the procedure. At 5 years, vessels with compromised and poor runoff had significantly worse cumulative
patency (82  9%, 56  4%, and 52  7% for Good, Compromised, and Poor runoffs, respectively, mean  standard error
of the mean [SEM]). Freedom from recurrent symptoms (65  8%, 39  9%, and 18  9% for Good, Compromised, and
Poor runoffs, respectively) and limb salvage (65  5%, 41  4%, and 20  6% for Good, Compromised, and Poor runoffs,
respectively) were incrementally curtailed by worsening runoff with significant decreases as runoff category deteriorated.
Conclusions: In patients presenting with rest pain and tissue loss who are treated with SFA percutaneous interventions,
patency is negatively affected by compromised and poor runoffs in keeping with the bypass literature. More importantly,
freedom from recurrent symptoms and limb salvage are incrementally curtailed as runoff scores worsen. These findings
are consistent with the bypass literature. ( J Vasc Surg 2008;48:619-26.)INTRODUCTION
Critical ischemia remains a significant problem in vas-
cular surgery and is associated with significant perioperative
morbidity and mortality. As a result, a greater emphasis is
being placed on aggressive endoluminal therapy, which
appears to carry reduced perioperative mortality and mor-
bidity.1 Interventions for superficial femoral artery (SFA)
occlusive disease is now commonplace and over fifty per-
cent is performed for critical limb ischemia.2 The implica-
tions of tibial vessel runoff on the long-term outcomes of
these endoluminal interventions in patients with rest pain
and tissue loss are unclear. Runoff is known to negatively
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doi:10.1016/j.jvs.2008.04.013effect graft patency in both experimental models of bypass
grafting and in multiple clinical reports.3-5 In a previous
report, we examined the impact of the arbitrary number of
patent tibial vessels on outcomes and showed that patency
was decreased in patients with 0-1 tibial vessel runoff.6
While such a simple scoring system has ease of use, the
Society of Vascular Surgery (SVS) system which scores the
site and the degree of occlusive disease in each runoff vessel
on two scales of 0-3 appears to be more accurate.7 It is not
known if runoff will impact the patency of SFA interven-
tions in the critical ischemic limbs. The aim of this study is
to examine the impact of distal popliteal and tibial runoff
using the modified SVS criteria on long-term outcomes of
SFA interventions for critical ischemia.
METHODS
Study design. A database of patients undergoing en-
dovascular treatment of the SFA between 1986 and 2007
was queried. Patients with Rutherford symptom classifica-
tion 4, 5, and 6 were selected. Patients with concomitant
distal popliteal and tibial interventions were excluded. An-
giograms were reviewed in all cases to assess distal popliteal
and tibial runoff. Pre-procedure runoff was scored accord-
ing to a modification of the SVS criteria such that a higher
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score groups were identified: 5 (Good), 5-10 (Compro-
mised), and 10 (Poor) and these groups were used for
subsequent analysis.
Methodology. For each patient captured, demo-
graphics, symptoms, existing co-morbid conditions, and
risk factors for atherosclerosis were identified (Appendix,
online only). For each patient, risk factors were identified
and corrected through their primary care providers. Ther-
apy for individual patients was dictated by individual at-
tending physician preference and was not regulated by unit
guidelines. Patients were preferentially offered endolumi-
nal intervention if appropriate prior to referral for bypass
surgery. All patients received aspirin daily (81 mg or 325
mg) as a general cardiovascular protection agent. Three
patients (0.9%) were on coumadin at the time of the
intervention, and this was continued after the procedure.
Patients with serious symptoms or signs of severe stenosis/
occlusion based upon the initial non-invasive tests received
angiograms. Angiograms and angiographic reports were
reviewed, lesions were categorized under the TASC-II
system.8 The distal runoff was scored according to a mod-
ification of SVS criteria employed for determining bypass
runoff (using the cumulative score for the distal popliteal
[maximum 9 1], and each of the tibial vessels [maximum
9 each] giving a maximum possible total score of 19). The
relationship with arbitrary tibial vessel runoff scoring from
our previous manuscript is shown in Fig 1, A (online
only).6 The correlation co-efficient was r2  0.74. An-
gioplasty was performed under systemic heparin adminis-
tration (40-60 units/kg), and completion angiography was
performed to assess the technical result. Stents were utilized
(at the discretion of the operator) primarily or as an adjunct
for flow-limiting dissections, intimal flaps, or poor technical
results (50% residual stenosis). No procedures or inter-
ventions were performed that could have potentially jeop-
ardized the outflow vessel. A glyco protein (GP) IIb/IIIa
inhibitor (abciximab 3.75 mcg/kg/hr for 12 hours) was
used at the discretion of the primary operator when
thought to provide benefit. Patients who had a successful
endoluminal intervention received 75 mg of clopidogrel.
While a patient was on clopidogrel, aspirin therapy was
maintained at 81 mg per day. Patients who were already on
clopidogrel prior to the intervention were left on clopi-
dogrel after the intervention. Patients underwent routine
clinical, Ankle Brachial Index (ABI) measurement and du-
plex scan follow-up at 1, 3, and 6 months after the proce-
dure, and every 6 months thereafter. Runoff vessels were
duplexed when the ABI dropped and no proximal or SFA
lesions were identified. During follow-up, angiograms were
only performed if patients were symptomatic and non-
invasive studies suggested restenosis/occlusion. Median
follow-up was 0.99 years (range, 0-11.5) and patient sur-
vival was confirmed in the Social Security Death Index.
Statistical analysis. All statistical analyses were per-
formed on an “intention-to-treat” basis. Measured values
are reported as percentages or means  standard deviation
(SD). Limb salvage rates are calculated using life tableanalysis and reported using current SVS criteria.7 Standard
errors are reported in life table analyses. Cox proportional
hazard analyses and multivariate analysis were performed to
identify factors associated with outcomes. Analyses were
performed using JMP software, version 5.0.1 (SAS Insti-
tute, Cary, NC).
RESULTS
Patient population. Five hundred twenty-five limbs
in 437 patients underwent endoluminal treatment of the
superficial femoral artery over the study period. In this same
time period, 1242 femoro-popliteal bypasses (49% for crit-
ical ischemia) were also performed. In the endoluminal
cohort, 306 limbs in 241 patients (57% male, average age
68 years) presented with critical ischemia (44% rest pain and
56% tissue loss). The relevant cardiovascular co-morbidities
are shown in Table I. The distribution of runoff scores 5
(Good), 5-10 (Compromised), and10 (Poor) were 30%,
45%, and 25%, respectively. There was no difference in the
co-morbidities between the groups. There was a significant
trend to symptoms of tissue loss as runoff worsened (2 for
trend  9.359, P  .0022). Trans-Atlantic Inter-Society
Consensus (TASC)-II lesion categories were evenly distrib-
uted across the groups (Table II). However, the proportion
of TASC A lesions in the Good group was significantly
greater (P  .004) compared to the combined Compro-
mise and Poor groups. Overall, survival in this cohort of
patients by life table analysis was 67% at 5 years; however, a
runoff score category Good (82%) was associated with
significantly better survival compared to the other runoff
Table I. Characteristics of patients presenting with
ischemia*
Good
(5)
Compromised
(5-10)
Poor
(10)
Demographics
Patients 77 114 68
Limbs treated 92 137 77
% Male 65% 57% 48%
Average age (years) 65  14 68  16 71  16
Demographics
Rest pain 51% 33% 30%
Tissue loss 49% 67% 70%
Comorbidities
Smoking history 73% 80% 86%
Current smoker 22% 15% 18%
CAD 58% 54% 58%
Hypertension 91% 87% 92%
Diabetes 63% 67% 75%
Hyperlipidemia 55% 61% 61%
Metabolic syndrome 58% 70% 64%
Cerebrovascular 19% 15% 13%
Chronic kidney disease† 31% 37% 39%
Hypothyroidism 12% 18% 22%
CAD, coronary artery disease.
*P  .05.
†10%, 19%, and 15% of the patients in each respective group were on
hemodialysis.score categories (59% and 59% at 5 years for Compromised
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systemic atherosclerotic burden (Fig 1, B online only). By
Cox proportional analysis, factors that contributed to de-
creased survival were the presence of endstage renal disease
on dialysis (relative risk [RR], 4.09. 2.29-7.44, P  .001),
hyperlipidemia (RR 2.21. 1.25-4.06, P .001) and diabe-
tes (RR 2.14, 1.15-4.24, P .01). By multivariate analysis,
statin therapy was found to have a positive impact on
survival (odds ratio [OR], 0.49, 0.34-0.71, P  .001).
Immediate outcomes. Technical success was 96% in
this cohort of patients; 61% SFA undergoing angioplasty,
37% SFA received primary stenting, and 2% SFA underwent
atherectomy. The acute failure rates (failure to traverse an
occlusion or occlusion within 30 days) were 4%, 2%, and 6%
for the runoff score categories Good, Compromised, and
Poor, respectively. In those cases with runoff score catego-
ries of Good and Compromised, concomitant aorto-iliac
interventions were more common than in the Poor runoff
group (Table II). Conversely, the need for thrombolysis or
distal embolectomy was more common in the runoff score
categories Compromised and Poor groups (Table II). Dis-
tal embolization did impact runoff by an average of two
points but this was not significant in this series. Overall
change in ABIs was 0.27  0.02 with 73% of patients
showing an ABI increase of 0.15 (Table II); those limbs
with a poor runoff demonstrated a significantly lower in-
crease in ABI and fewer patients achieved an increase in ABI
0.15 compared to the Good and compromised runoff
groups (Table II). Overall mortality was 0.7% and 1% and
overall morbidity was 14% and 16% at 30 and 90 days,
respectively, after the procedure. The overall complication
rates were 14%, 18%, and 13% for the Good, Compro-
mised, and Poor runoff groups (Table IV, online only).
There were no differences in general or access-specific
complications across the groups but there was a trend to
more site of intervention-specific complications as the cat-
Table II. Location of disease, TASC-II category,
adjunctive procedures, and hemodynamic changes
Good (5)
Compromised
(5-10) Poor (10)
TASC Category
A 42% 18% 24%
B 18% 29% 25%
C 22% 31% 28%
D 17% 22% 22%
Stent usage 13% 16% 22%
Adjunct procedures
Aorto-iliac
intervention 12% 12% 4%*
Thrombolysis/
embolectomy 8% 14% 12%
Hemodynamic changes
Change in ABI 0.32  0.05 0.29  0.03 0.17  0.06*
% ABI increase
0.15 84% 75% 54%*
ABI, ankle brachial index.
Note: *P  .05.egory of runoff worsened (Table IV, online only).Long term outcomes. Overall, in this cohort of pa-
tients with critical ischemia, freedom from recurrent symp-
toms was 29  7% and limb salvage was 46  10% at 5
years. Freedom from recurrent symptoms could be seg-
mented by runoff category (65  8%, 39  9%, and 18 
9% at 5 years for runoff score category Good, Compro-
mised, and Poor, respectively; P .01; Fig 2,A). While the
absolute numbers of restenosis were higher in the Good
and Compromised groups, the absolute numbers of occlu-
sion were higher in the Poor runoff group (P  .05).
However, by life table analysis, restenosis rates were equiv-
alent across the groups (Fig 1, C online only). Those
patients with Compromised and Poor runoff demonstrated
progression of distal disease over time (Table III). Factors
that contributed to decreased freedom from recurrent
symptoms were the severity of the presenting symptom
(RR 1.68, 0.96-2.95 P .05); the presence of endstage
renal disease on dialysis; hyperlipidemia and diabetes did
not affect this measure. By multivariate analysis, the pres-
Fig 2. Functional Outcomes. Life table analysis of freedom
from recurrent symptoms (A), limb salvage (B) in each of the
runoff score categories (Good -5, Compromised - 5-10 and
Poor - 10). The number of vessels or limbs at risk at each time
interval is shown below the figure.ence of a hypercoaguable state (OR 2,26, 1.64-3.5,
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2.27, P  .006) were found to have a negative impact on
the occurrence of recurrent symptoms. Limb salvage was
incrementally curtailed by worsening runoff with signifi-
cant decreases as category of runoff worsened (65  5%,
41  4%, and 20  6% at 5 years for runoff score category
Good, Compromised, and Poor, respectively; P  .01; Fig
2, B). Factors that contributed to decreased limb salvage
were the severity of the presenting symptom (RR 6.33,
1.69-8.16, P  .05) and the presence of endstage renal
disease on dialysis (RR 5.39, 1.16-24.5, P  .03). Neither
hyperlipidemia nor diabetes affected this measure. By mul-
tivariate analysis, presence of a hypercoagulable state (OR
1.28, 0.66-2.89, P  .01) was found to be associated with
major amputation. Seventeen percent, 27%, and 44% major
amputations (below knee amputation [BKA] or above knee
amputation [AKA]) were performed in runoff score cate-
gory Good, Compromised, and Poor, respectively (Table
III). There was a 3.4-fold increase in AKAs in the runoff
score category Poor compared to the other two groups
(P  .05). By multivariate analysis, statin therapy was
associated with less recurrent symptoms (OR 0.38, 0.26-
0.56, P  .05) and improved limb salvage (OR 0.46,
0.33-0.64, P  .05). Overall, freedom from target lesion
revascularization (TLR) was 37% at 5 years. Freedom from
TLR for vessels with Good runoff category (67%) was
superior to both the Compromised (46%) and Poor (48%)
runoff categories at three years (P  .05, Fig 1, D, online
only). This was also reflected in the primary and assisted
primary patency rates (Fig 3, A and B). At 5 years, vessels
with a runoff score category of 5 or greater (Compromised
or Poor) had significantly worse cumulative patency com-
pared to Good (secondary patency: 82 9%, 56 4%, and
52  7% for Good, Compromised, and Poor, respectively;
P  .01) (Fig 3, C). We did not see a significant difference
in subsequent interventions for defined occlusive lesions
proximal or distal to the SFA/popliteal segment. In con-
Table III. Subsequent outcomes
Good
(5)
Compromised
(5-10)
Poor
(10)
Causes of recurrent symptoms
Restenosis 5% 9% 0%
In-stent restenosis 3% 1% 0%
Occlusion 2% 4% 7%*
Progression of proximal disease 1% 1% 3%
Progression of distal disease 5% 9% 7%
Subsequent interventions
Lesion re-intervention 11% 12% 3%
Proximal Intervention 3% 2% 0%
Distal intervention 4% 2% 0%
Bypass 5% 9% 14%*
Subsequent amputations
Toes and forefoot 7% 8% 5%
Below knee 12% 18% 27%
Above knee 5% 9% 17%*
*P  .05.trast, there was a significant difference in lesion specificinterventions with the runoff categories, Good and Com-
promised, having a four-fold incidence of repeat percuta-
neous intervention compared to the runoff category, Poor,
where there was a two-fold higher incidence of subsequent
bypass surgery (Table III). Factors that contributed to
decreased patency were hypertension (RR 1.23, 1.07-2.63,
P .043), hyperlipidemia (RR 2.66, 1.03-7.56, P .013)
and diabetes (RR 3.48, 1.86-12.3, P  .014). Mode of
intervention did not affect these measures. By multivariate
analysis, worsening presenting symptomatology (OR 1.95,
1.31-2.91, P  .05) and TASC-II category (OR 1.95,
1.31-2.91, P  .05) were associated with worsening TLR
and all measures of patency.
DISCUSSION
This study confirms that SFA interventions in patients
with critical ischemia have a high technical success rate with
a low mortality and morbidity. Measures of survival and
patency are affected by worsening runoff scores. More
importantly, the measures that measure patient lifestyle,
namely freedom from recurrent symptoms and limb salvage
are incrementally curtailed as runoff scores worsen. Major
AKAs are more common with deteriorating runoff. It has
been reported that lower procedural event rates and asso-
ciated costs coupled to short term results that are compa-
rable to those of bypass surgery supported the increasing
role of endoluminal therapy for critical ischemia as a first
line modality.9 Failure of endoluminal therapy for treat-
ment of lower extremity arterial occlusive disease is amena-
ble to subsequent endovascular intervention for limb
salvage with limited morbidity and mortality.10,11 An
increasing number of multisegment and more complicated
arterial lesions are currently being treated but the greater
the complexity of the endoluminal case, the poorer appear
to be the final outcomes.12,13 Few have examined the
impact on the success of endoluminal therapy of runoff in
patients with critical ischemia.
Anatomical criteria to define peripheral vascular runoff
have been standardized by the 1997 revised SVS runoff
score.7 Although this score accurately incorporates anasto-
motic site, degree of occlusion, and pedal arch integrity, the
use of this scoring system has not consistently predicted
graft patency, limb salvage, or survival.14-16 It has not been
employed previously for endoluminal interventions. Bian-
cari et al14 examined the ability of the runoff score to
predict hemodynamic success, immediate graft patency,
and overall graft patency. Although they demonstrated that
low runoff scores predicted hemo-dynamic success after
infrainguinal bypass, these scores did not predict immediate
or overall patency. A subgroup of grafts with widely patent
outflow (runoff score, 1) did demonstrate excellent patency
and limb salvage rates compared with all other runoff
scores. Several other series have reported similar results
using the SVS runoff score or modifications thereof.15-17 In
this study, we used a modified Rutherford scoring system,
which incorporated both the distal popliteal and individual
runoff scores. This allowed us to quantify both the contri-
bution of the popliteal artery and the tibial vessels to
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with the arbitrary tibial vessel scoring system often em-
ployed by other studies. Thirty percent of the patients
presenting with critical ischemia had “good runoff”. Ap-
proximately 10% of these patients had concomitant aorto-
iliac interventions, which would be consistent with two-
level disease and explain anatomically the presence of
critical ischemia. However, the presence of diabetic
(60%) and chronic renal insufficiency (31%) likely con-
tributed to the presenting symptoms due to their underly-
ing small vessel disease.
Patients with critical limb ischemia manifested by rest
pain and/or tissue loss are considered higher risk surgical
candidates. We had low periprocedural mortality and mor-
bidity in these groups of patients and these numbers did not
differ from reports on endoluminal therapy for claudica-
tion.2 Several other studies have suggested that endovascu-
Fig 3. Cumulative Patency. Life table analysis of prim
patency (C) in each of the runoff score categories (Goo
significant difference in primary patency between the thr
patency is significantly superior in the Good runoff com
number of vessels or limbs at risk at each time interval islar intervention should be considered prior to open surgeryas it carries a lower peri-procedural morbidity and does not
compromise limb salvage and subsequent vascular inter-
vention, in comparison to bypass surgery.10,18-20 Histori-
cally, lower extremity critical ischemia has been associated
with high death rates over the longer term: 20% to 27% at 1
year,4,21 32% at 2 years22 and more than 60% at 5 years.23
We found that overall survival in this cohort of patients was
67% at 5 years (mortality of 33%). This is likely linked to a
lower initial periprocedural event rate and the widespread
introduction of risk factor reduction measures in the pop-
ulation. A good runoff score did predict superior survival
compared to poor runoff. Systemic factors of hyperlipid-
emia and diabetes and hemodialysis dependent endstage
renal disease contributed to decreased survival. The litera-
ture is not consistent on this subject with multiple studies
suggesting that quantification of runoff is not a predictor of
survival14-16,24 and others suggesting that there is a rela-
atency (A), assisted primary patency (B) and secondary
5, Compromised - 5-10, and Poor - 10). There is a
oups (P .05). Assisted primary patency and secondary
to the Compromised and Poor groups (P  .05). The
n below the figure.ary p
d -
ee gr
pared
showtionship.25
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femorotibial and peroneal bypasses is dependent on the
inflow state, the availability of a venous conduit, the num-
ber of calf vessels, the presence of straight flow to the foot
and the presence of patent pedal vessels.5,26 Biancari et al14
demonstrated that a better runoff reflected in low runoff
scores will predict hemodynamic success after infrainguinal
bypass, but that scoring runoff did not allow on to predict
immediate or overall patency. However, in those patients
with a widely patent and undiseased outflow (runoff score,
1), there were excellent patency rates compared with all
other runoff scores categories. Several other series have
reported similar results using the SVS runoff score or
modifications thereof.15-17 Limb-threatening ischemia as
the indication for endoluminal intervention is most highly
associated with failure of both primary and secondary pa-
tency and has been associated with four indicators of lesion
severity and treatment complexity, including increasing
TASC grade, multilevel intervention, tibial intervention,
and reduced tibial outflow.13 In this study, TASC-II lesion
severity increased as runoff became worse. Black et al1
showed that insulin-dependent diabetes mellitus, poor run-
off into the foot, and renal insufficiency (serum creatinine
1.5 mg/dL) were predictive of endoluminal failure. We
have also shown that diabetes will impact limb salvage
particularly in patients with tissue loss and that stage of
renal disease does impact both patency and limb sal-
vage.27,28 An important question is whether concomitant
tibial intervention will alter patency. DeRubertis et al13
have suggested that multilevel interventions and those as-
sociated with tibial intervention have worse outcomes than
single level interventions.
Several previous studies have failed to demonstrate an
overall correlation between angiographic runoff score and
limb salvage.14,16,17 However, these studies did not in-
clude substantial numbers of patients with extremely com-
promised outflow (tibial runoff score, 10 using the stan-
dardized SVS system). Ascer et al have demonstrated
inferior limb salvage rates with very high hemodynamic
outflow resistance.3,29 Desai et al have shown that scores
reflecting blind outflow are a marker for limb loss.24 These
data would support our findings that limb salvage after
endoluminal intervention is dependent on runoff. The
current study suggests that SFA interventions are associated
with poor long-term limb salvage. When infra-inguinal
bypasses are required for limb salvage, it appears that the
most common primary causes of limb loss in the first 30
days is overwhelming progression of soft-tissue infection
despite patent bypass (44%) and insufficient runoff in the
foot (33%).30 We did see an association of tissue loss with
poor limb salvage and recurrent symptoms. ESRD was also
a poor prognosticator for limb salvage and it is known that
for the subgroup of patients with ESRD, a heel ulcer more
than 4 cm was suggestive of an unsalvageable foot despite a
patent bypass.31 For the subgroup of patients with ESRD,
age, and runoff score of the SVS, isolated tibial bypass graft,
and location of distal anastomosis were not predictive of
hemodynamic failure. Further data from Seeger et al25 hasdemonstrated that amputation is significantly more com-
mon in patients with poor runoff scores (poor runoff,
44.4% vs. good runoff, 7.4%; P  .01). Runoff score was
the strongest predictor of outcome, with 70% of patients
with poor runoff scores having death, amputation, or graft
failure.25 The limb salvage rates after bypass surgery can
also be correlated with foot runoff score (scores of dorsalis
pedis, lateral plantar, and medial plantar arteries) (P 
.05).5 One prospective study of patients with severe lower
limb ischemia reported that endovascular intervention and
bypass surgery achieved the same limb salvage rates at 1
year.32 The majority of studies of bypass grafts for limb
salvage have shown significantly better limb salvage than we
report for SFA interventions. However, initial attempts of
endoluminal intervention can be used in the management
of lower extremity ischemia without compromising limb
salvage, patient survival, and subsequent vascular interven-
tion, in comparison to bypass surgery.18 The bypass vs
angioplasty in severe ischemia of the leg (BASIL) study has
demonstrated equivalence when infra-popliteal interven-
tions are undertaken.33
In patients presenting with rest pain and tissue loss who
are treated with SFA percutaneous interventions, patency
and target lesion revascularization is negatively affected by
worsening runoff. More importantly, freedom from recur-
rent symptoms and limb salvage are incrementally curtailed
as runoff scores worsen. This data is consistent with data
observed in the bypass literature. The implications of this
report are that patients with compromised and poor runoff
may not benefit from a percutaneous intervention and may
be better served with bypass surgery, if appropriate.
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Dr John F. Eidt (Little Rock, Ark) I want to thank Mark
G. Davies and the other authors for providing me with a copy
of the manuscript well in advance of the meeting. There is a lot
of information and I commend the authors for a thorough
analysis.
The premise of the current manuscript is that runoff might
have a different effect on the outcome from percutaneous inter-
vention than following conventional surgery. Numerous surgical
authors have tried to correlate the anatomic and/or physiologic
runoff with the results of vascular reconstruction for decades with
varying degrees of success.
In short, runoff matters. In the present study, runoff scores
correlated with most measurable outcomes including limb salvage,
patency, recurrence of symptoms and need for target lesion revas-disease as demonstrated by the fact that overall survival in this study
was related to the runoff score.
It would be tempting to conclude that these results support
the preferential use of percutaneous options in patients with critical
limb ischemia (CLI) with better runoff. The overall limb salvage
was somewhat less than 50% at 5 years. Is this the best we can do?
Since this is a highly-selected group of patients without a compar-
ison group of any kind, I would caution that it is hazardous to use
these data to support any particular treatment option.
I have four questions.
The first question is related to your terminology. Is Target
Lesion Revascularization (TLR) an appropriate measure of efficacy
in patients with CLI? Does TLR include amputations?
Second, there was a conspicuous absence of physiologic data
such as ankle brachial indices (ABIs) to support the efficacy of
JOURNAL OF VASCULAR SURGERY
September 2008626 Davies et altreatment. Do you have any non-invasive data to corroborate the
initial clinical classification and, more importantly, the effect of
treatment?
Third, I have had the unfortunate experience of losing runoff
vessels as the result of proximal intervention. I noticed that embo-
lectomy or thrombolysis was necessary in 8-14% of your patients.
Did you observe examples in which the percutaneous intervention
resulted in a deterioration of the anatomic runoff score?
Finally, our goal is to select the best treatment for a single
patient. In your series, only about 10% of patients ever had surgical
intervention. Do you have any idea how many patients were
treated surgically at your institution for similar indications during
the same time period? How were patients selected for percutane-
ous treatment? Should more of these patients been referred for
definitive surgical reconstruction?
Dr Mark G. Davies. There are several definitions of target
lesion revascularization. The definition we used is a composite
measure of success used in several recent papers. Freedom from
target lesion revascularization (TLR) was defined as the absence of
clinically driven repeat revascularization of the target lesion (endo-
vascular therapy for symptomatic stenosis) or the need for surgical
bypass grafting or amputation due to re-occlusion of the target
lesion as diagnosed by arteriography or duplex scan. We also
included the patency and limb salvage rates with the different types
of amputations so that one can differentiate out the reasons for
TLR. With regard to the non-invasives studies and post procedureABI improvement, the high incidence of diabetes in this study
group meant there were many patients with noncompressive ves-
sels (20% who do not have meaningful ABI data). Many did not
get toe pressure measurements. Since this data is garnered from the
experience of a multidisciplinary service line and not a primary
vascular surgery service, there is a fraction of patients that had no
initial non-invasive data. Of those that do, 80% of them did have a
hemodynamic improvement.With regard to loss of runoff, we have
about a 1% embolization rate, which necessitated embolectomy.
We did go through a period early in our experience, where we
would try to lyze distal emboli, but it is generally plaque; we now
go straight to embolectomy and not delay 24 hrs to see if lysis will
work. The higher use of thrombolysis is related to in situ throm-
bosis and in that case, we would use thrombolysis for a period of
one to two days. Previous reports, however, show that use of
thrombolysis during an SFA intervention is associated with a
decrease in cumulative patency. The main message of this paper is
that while endoluminal intervention is safe and technically success-
ful it may not be correct primary modality in the fit patient with
poor runoff. The physician undertaking the procedure needs to
more critically analyze the chances for success and consider referral
for open surgery. The second point to emphasize is that runoff
matters irrespective of the treatment modality used and that ex-
trapolation of results from other organs with regard to runoff is not
applicable in the leg.
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Definitions: Coronary artery disease was defined as a
history of angina pectoris, myocardial infarction, conges-
tive heart disease, or prior coronary artery revasculariza-
tions. Cerebrovascular disease was defined as a history of
stroke, transient ischemic attack, or carotid artery revas-
cularization. Non-insulin dependent diabetes mellitus
(NIDDM)was defined as any patient with diabetes mellitus
who does not routinely receive insulin therapy in their
diabetes management. Insulin dependent diabetes mellitus
(IDDM) was defined as any patient with diabetes mellitus
who does routinely receive insulin therapy. Chronic renal
impairment was defined as a serum creatinine level of 1.5
mg/dL (132.6 	mol/L) or greater or a patient on dialysis.
Hypertension was defined as a systolic blood pressure
150 mmHg or diastolic blood pressure 90 mmHg on
three occasions during a six-month period. Hypercholes-
terolemia was defined as fasting serum concentrations of
cholesterol 200 mg/dL, a low density lipoprotein
130 mg/dL or triglycerides200 mg/dL. Diabetes was
defined as a fasting plasma glucose 110 mg/dL or a
hemoglobin A1c 7%. Metabolic syndrome was defined as
previously described [Grundy, 2004 #41] (insulin resis-
tance or impaired glucose tolerance, hypertension, dyslipi-demia, and abdominal obesity), with the exception of ab-
dominal circumference, which was not routinely recorded.
We substituted a body mass index score27.0 as a positive
score instead of an abdominal circumference 102 cm or
88 cm for male or female patients, respectively. Hyperco-
aguable state was defined as hematological proof of a
known hypercoaguable disorder or the administration of
long term coumadin for thrombotic events. Trans Atlantic
Inter-Society Consensus (TASC)-II classification of disease
severity for femoral lesions was used to define the categories
of lesions [TASC II Working Group, 2007 #40]. A death
within 30 days of the procedure was considered procedure-
related. A major complication was defined as any event,
regardless of how minimal, not routinely observed after
endoluminal therapy that required treatment with a ther-
apeutic intervention or re-hospitalization within 30 days
of the procedure. Freedom from target lesion revascular-
ization (TLR) was defined as the absence of clinically
driven repeat revascularization of the target lesion (en-
dovascular therapy for symptomatic stenosis) or the need
for surgical bypass grafting or amputation due to re-occlusion
of the target lesion as diagnosed by arteriography or duplex
scan. Pre- and post-procedural symptoms were defined by
SVS criteria [Rutherford, 1997 #3] and a drop of one or
greater in follow-up was considered as recurrent symptoms.
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September 2008626.e2 Davies et alFig 1 (online only). (A) The inverse relationship between the modified SVS score and the arbitrary tibial vessel
scoring system. The r20.76 with y4.9001x 16.481 the best equation to describe the binominal function of
the trend line. (B) Survival. Life table analysis of patient survival for the patients in each of the runoff score categories
(Good -5, Compromised - 5-10, and Poor -10). The number of patients at risk at each time interval is shown below
the figure. (C) Restenosis. Life table analysis of restenosis in each of the runoff score categories (Good -5,
Compromised - 5-10, and Poor -10). The number of vessels or limbs at risk at each time interval is shown below the
figure. (D) Target Lesion Revascularization (TLR): Life table analysis of TLR in each of the runoff score categories
(Good -5, Compromised - 5-10, and Poor -10). The number of vessels at risk at each time interval is shown below
the figure.
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Good
(5)
Compromised
(5-10)
Poor
(10)
General
30-day mortality
Cardiac 0% 1% 1%
Pulmonary 0% 2% 0%
Renal 1% 2% 3%
Infection 0% 1% 0%
Site specific
Occlusion 4% 2% 7%*
Embolization 5% 4% 7%
Dissection 5% 5% 1%
Perforation 1% 3% 4%
Access specific
Hematoma 4% 2% 1%
Bleeding 0% 0% 0%
Pseudoaneurysm 0% 2% 1%*Note: P  .05.
